Keywords: immunex, anticancer, agent, mitoxantrone, backed, advanced, multiple

Immunex' anticancer agent, mitoxantrone, backed for advanced multiple

Article | 02 February 2000

Immunex Corp has received unanimous backing from a US Food and DrugAdministration advisory committee for an expanded indication for its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in